Invesco’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $676M | Buy |
|
|||||
|
2025
Q2 | $438M | Buy |
|
|||||
|
2025
Q1 | $247M | Buy |
|
|||||
|
2024
Q4 | $131M | Sell |
|
|||||
|
2024
Q3 | $191M | Buy |
|
|||||
|
2024
Q2 | $95.5M | Buy |
|
|||||
|
2024
Q1 | $26.6M | Buy |
|
|||||
|
2023
Q4 | $33.9M | Sell |
|
|||||
|
2023
Q3 | $38.4M | Sell |
|
|||||
|
2023
Q2 | $74.1M | Buy |
|
|||||
|
2023
Q1 | $73.6M | Sell |
|
|||||
|
2022
Q4 | $159M | Sell |
|
|||||
|
2022
Q3 | $148M | Buy |
|
|||||
|
2022
Q2 | $24.6M | Sell |
|
|||||
|
2022
Q1 | $158M | Buy |
|
|||||
|
2021
Q4 | $151M | Sell |
|
|||||
|
2021
Q3 | $199M | Buy |
|
|||||
|
2021
Q2 | $170M | Sell |
|
|||||
|
2021
Q1 | $172M | Sell |
|
|||||
|
2020
Q4 | $166M | Buy |
|
|||||
|
2020
Q3 | $159M | Sell |
|
|||||
|
2020
Q2 | $167M | Buy |
|
|||||
|
2020
Q1 | $80.5M | Buy |
|
|||||
|
2019
Q4 | $66.6M | Buy |
|
|||||
|
2019
Q3 | $43.7M | Buy |
|
|||||
|
2019
Q2 | $36M | Buy |
|
|||||
|
2019
Q1 | $19.4M | Buy |
|
|||||
|
2018
Q4 | $1.27M | Buy |
|
|||||
|
2018
Q3 | $1.27M | Sell |
|
|||||
|
2018
Q2 | $13.1M | Buy |
|
|||||
|
2018
Q1 | $6.64M | Sell |
|
|||||
|
2017
Q4 | $9.2M | Sell |
|
|||||
|
2017
Q3 | $9.5M | Buy |
|
|||||
|
2017
Q2 | $2.33M | Sell |
|
|||||
|
2017
Q1 | $8.72M | Buy |
|
|||||
|
2016
Q4 | $5.82M | Buy |
|
|||||
|
2016
Q3 | $7.71M | Buy |
|
|||||
|
2016
Q2 | $681K | Sell |
|
|||||
|
2016
Q1 | $8.19M | Sell |
|
|||||
|
2015
Q4 | $37.5M | Sell |
|
|||||
|
2015
Q3 | $42.9M | Sell |
|
|||||
|
2015
Q2 | $84.8M | Buy |
|
|||||
|
2015
Q1 | $55.3M | Buy |
|
|||||
|
2014
Q4 | $51.3M | Buy |
|
|||||
|
2014
Q3 | $40.3M | Buy |
|
|||||
|
2014
Q2 | $31.5M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $24K | Sell |
|
|||||
|
2013
Q3 | $3.62M | Sell |
|
|||||
|
2013
Q2 | $5.03M | Buy |
|